Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Race Oncology Ltd. ( (AU:RAC) ) just unveiled an announcement.
Race Oncology Ltd has announced the quotation of 497,031 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of December 4, 2025. This move is part of the company’s strategic efforts to enhance its financial positioning and increase its market presence, potentially impacting stakeholders by providing more liquidity and investment opportunities.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology and pharmaceuticals industry, focusing on the development and commercialization of cancer therapies.
Average Trading Volume: 565,618
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$509.1M
For detailed information about RAC stock, go to TipRanks’ Stock Analysis page.